カテゴリ： 世界, 医療/バイオ, Market Monitor Global

人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）のグローバル市場展望 2023年-2029年：バイアル、充填済み

■ 英語タイトル：Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14329）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14329
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：72
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）のグローバル市場展望 2023年-2029年：バイアル、充填済み]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場規模と予測を収録しています。・世界の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場：売上、2018年-2023年、2024年-2029年
・世界の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「バイアル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）のグローバル主要企業は、Sanofi Pasteur、 Serum Institute of India Pvt.、 Bavarian Nordic、 AimBio、 Kangtai、 Yisheng Biopharma、 Minhai Biotechnologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場：タイプ別、2018年-2023年、2024年-2029年
世界の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場：タイプ別市場シェア、2022年
・バイアル、充填済み

世界の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場：用途別、2018年-2023年、2024年-2029年
世界の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場：用途別市場シェア、2022年
・病院、研究所、診療所、CDC、その他

世界の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場：地域・国別、2018年-2023年、2024年-2029年
世界の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）のグローバル売上、2018年-2023年
・主要企業における人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）のグローバル売上シェア、2022年
・主要企業における人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）のグローバル販売量、2018年-2023年
・主要企業における人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Sanofi Pasteur、 Serum Institute of India Pvt.、 Bavarian Nordic、 AimBio、 Kangtai、 Yisheng Biopharma、 Minhai Biotechnology

*************************************************************

・調査・分析レポートの概要
人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場の定義
市場セグメント
世界の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場規模
世界の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場規模：2022年 VS 2029年
世界の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：バイアル、充填済み
人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、研究所、診療所、CDC、その他
人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）の用途別グローバル売上・予測

・地域別市場分析
地域別人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）市場規模 2022年と2029年
地域別人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi Pasteur、 Serum Institute of India Pvt.、 Bavarian Nordic、 AimBio、 Kangtai、 Yisheng Biopharma、 Minhai Biotechnology
...

This research report provides a comprehensive analysis of the Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Freeze-Dried Human Rabies Vaccine (Human Diploid Cells), challenges faced by the industry, and potential opportunities for market players.
The global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market presents opportunities for various stakeholders, including Hospital, Laboratory. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market. Additionally, the growing consumer demand present avenues for market expansion.
The global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market.
Market Overview: The report provides a comprehensive overview of the Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Vials, Pre-filled), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Freeze-Dried Human Rabies Vaccine (Human Diploid Cells), including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Vials
Pre-filled
Market segment by Application
Hospital
Laboratory
Clinic
CDC
Others
Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Sanofi Pasteur
Serum Institute of India Pvt.
Bavarian Nordic
AimBio
Kangtai
Yisheng Biopharma
Minhai Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Freeze-Dried Human Rabies Vaccine (Human Diploid Cells), market overview.
Chapter 2: Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) market size in revenue and volume.
Chapter 3: Detailed analysis of Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Overall Market Size
2.1 Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size: 2022 VS 2029
2.2 Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales: 2018-2029
3 Company Landscape
3.1 Top Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Players in Global Market
3.2 Top Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Companies Ranked by Revenue
3.3 Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue by Companies
3.4 Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales by Companies
3.5 Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Players in Global Market
3.8.1 List of Global Tier 1 Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Companies
3.8.2 List of Global Tier 2 and Tier 3 Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size Markets, 2022 & 2029
4.1.2 Vials
4.1.3 Pre-filled
4.2 By Type – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue & Forecasts
4.2.1 By Type – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, 2018-2023
4.2.2 By Type – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, 2024-2029
4.2.3 By Type – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue Market Share, 2018-2029
4.3 By Type – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales & Forecasts
4.3.1 By Type – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, 2018-2023
4.3.2 By Type – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, 2024-2029
4.3.3 By Type – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales Market Share, 2018-2029
4.4 By Type – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Laboratory
5.1.4 Clinic
5.1.5 CDC
5.1.6 Others
5.2 By Application – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue & Forecasts
5.2.1 By Application – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, 2018-2023
5.2.2 By Application – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, 2024-2029
5.2.3 By Application – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue Market Share, 2018-2029
5.3 By Application – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales & Forecasts
5.3.1 By Application – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, 2018-2023
5.3.2 By Application – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, 2024-2029
5.3.3 By Application – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales Market Share, 2018-2029
5.4 By Application – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2022 & 2029
6.2 By Region – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue & Forecasts
6.2.1 By Region – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, 2018-2023
6.2.2 By Region – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, 2024-2029
6.2.3 By Region – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue Market Share, 2018-2029
6.3 By Region – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales & Forecasts
6.3.1 By Region – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, 2018-2023
6.3.2 By Region – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, 2024-2029
6.3.3 By Region – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, 2018-2029
6.4.2 By Country – North America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, 2018-2029
6.4.3 US Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.4.4 Canada Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.4.5 Mexico Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, 2018-2029
6.5.2 By Country – Europe Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, 2018-2029
6.5.3 Germany Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.5.4 France Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.5.5 U.K. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.5.6 Italy Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.5.7 Russia Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.5.8 Nordic Countries Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.5.9 Benelux Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, 2018-2029
6.6.2 By Region – Asia Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, 2018-2029
6.6.3 China Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.6.4 Japan Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.6.5 South Korea Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.6.6 Southeast Asia Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.6.7 India Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, 2018-2029
6.7.2 By Country – South America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, 2018-2029
6.7.3 Brazil Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.7.4 Argentina Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, 2018-2029
6.8.3 Turkey Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.8.4 Israel Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.8.5 Saudi Arabia Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
6.8.6 UAE Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Company Summary
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Major Product Offerings
7.1.4 Sanofi Pasteur Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Pasteur Key News & Latest Developments
7.2 Serum Institute of India Pvt.
7.2.1 Serum Institute of India Pvt. Company Summary
7.2.2 Serum Institute of India Pvt. Business Overview
7.2.3 Serum Institute of India Pvt. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Major Product Offerings
7.2.4 Serum Institute of India Pvt. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales and Revenue in Global (2018-2023)
7.2.5 Serum Institute of India Pvt. Key News & Latest Developments
7.3 Bavarian Nordic
7.3.1 Bavarian Nordic Company Summary
7.3.2 Bavarian Nordic Business Overview
7.3.3 Bavarian Nordic Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Major Product Offerings
7.3.4 Bavarian Nordic Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales and Revenue in Global (2018-2023)
7.3.5 Bavarian Nordic Key News & Latest Developments
7.4 AimBio
7.4.1 AimBio Company Summary
7.4.2 AimBio Business Overview
7.4.3 AimBio Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Major Product Offerings
7.4.4 AimBio Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales and Revenue in Global (2018-2023)
7.4.5 AimBio Key News & Latest Developments
7.5 Kangtai
7.5.1 Kangtai Company Summary
7.5.2 Kangtai Business Overview
7.5.3 Kangtai Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Major Product Offerings
7.5.4 Kangtai Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales and Revenue in Global (2018-2023)
7.5.5 Kangtai Key News & Latest Developments
7.6 Yisheng Biopharma
7.6.1 Yisheng Biopharma Company Summary
7.6.2 Yisheng Biopharma Business Overview
7.6.3 Yisheng Biopharma Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Major Product Offerings
7.6.4 Yisheng Biopharma Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales and Revenue in Global (2018-2023)
7.6.5 Yisheng Biopharma Key News & Latest Developments
7.7 Minhai Biotechnology
7.7.1 Minhai Biotechnology Company Summary
7.7.2 Minhai Biotechnology Business Overview
7.7.3 Minhai Biotechnology Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Major Product Offerings
7.7.4 Minhai Biotechnology Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales and Revenue in Global (2018-2023)
7.7.5 Minhai Biotechnology Key News & Latest Developments
8 Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Production Capacity, Analysis
8.1 Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Production Capacity, 2018-2029
8.2 Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Production Capacity of Key Manufacturers in Global Market
8.3 Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Supply Chain Analysis
10.1 Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Industry Value Chain
10.2 Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Upstream Market
10.3 Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) in Global Market
Table 2. Top Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue Share by Companies, 2018-2023
Table 5. Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales by Companies, (K Units), 2018-2023
Table 6. Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Product Type
Table 9. List of Global Tier 1 Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales (K Units), 2018-2023
Table 15. By Type - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales (K Units), 2024-2029
Table 16. By Application – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales (K Units), 2018-2023
Table 20. By Application - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales (K Units), 2024-2029
Table 21. By Region – Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales (K Units), 2018-2023
Table 25. By Region - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales (K Units), 2024-2029
Table 26. By Country - North America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, (K Units), 2018-2023
Table 29. By Country - North America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, (K Units), 2024-2029
Table 30. By Country - Europe Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, (K Units), 2018-2023
Table 33. By Country - Europe Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, (K Units), 2024-2029
Table 34. By Region - Asia Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, (K Units), 2018-2023
Table 37. By Region - Asia Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, (K Units), 2024-2029
Table 38. By Country - South America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, (K Units), 2018-2023
Table 41. By Country - South America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales, (K Units), 2024-2029
Table 46. Sanofi Pasteur Company Summary
Table 47. Sanofi Pasteur Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Product Offerings
Table 48. Sanofi Pasteur Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Sanofi Pasteur Key News & Latest Developments
Table 50. Serum Institute of India Pvt. Company Summary
Table 51. Serum Institute of India Pvt. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Product Offerings
Table 52. Serum Institute of India Pvt. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Serum Institute of India Pvt. Key News & Latest Developments
Table 54. Bavarian Nordic Company Summary
Table 55. Bavarian Nordic Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Product Offerings
Table 56. Bavarian Nordic Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Bavarian Nordic Key News & Latest Developments
Table 58. AimBio Company Summary
Table 59. AimBio Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Product Offerings
Table 60. AimBio Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. AimBio Key News & Latest Developments
Table 62. Kangtai Company Summary
Table 63. Kangtai Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Product Offerings
Table 64. Kangtai Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Kangtai Key News & Latest Developments
Table 66. Yisheng Biopharma Company Summary
Table 67. Yisheng Biopharma Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Product Offerings
Table 68. Yisheng Biopharma Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Yisheng Biopharma Key News & Latest Developments
Table 70. Minhai Biotechnology Company Summary
Table 71. Minhai Biotechnology Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Product Offerings
Table 72. Minhai Biotechnology Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Minhai Biotechnology Key News & Latest Developments
Table 74. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 75. Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Production by Region, 2018-2023 (K Units)
Table 77. Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Production by Region, 2024-2029 (K Units)
Table 78. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Opportunities & Trends in Global Market
Table 79. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Drivers in Global Market
Table 80. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Restraints in Global Market
Table 81. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Raw Materials
Table 82. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Raw Materials Suppliers in Global Market
Table 83. Typical Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Downstream
Table 84. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Downstream Clients in Global Market
Table 85. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Segment by Type in 2022
Figure 2. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Segment by Application in 2022
Figure 3. Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, 2018-2029 (US$, Mn)
Figure 7. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue in 2022
Figure 9. By Type - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue Market Share, 2018-2029
Figure 11. By Type - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales Market Share, 2018-2029
Figure 12. By Type - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue Market Share, 2018-2029
Figure 15. By Application - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales Market Share, 2018-2029
Figure 16. By Application - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue Market Share, 2018-2029
Figure 20. By Region - Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales Market Share, 2018-2029
Figure 21. By Country - North America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue Market Share, 2018-2029
Figure 22. By Country - North America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales Market Share, 2018-2029
Figure 23. US Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales Market Share, 2018-2029
Figure 28. Germany Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 29. France Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales Market Share, 2018-2029
Figure 37. China Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 41. India Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue Market Share, 2018-2029
Figure 43. By Country - South America Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales Market Share, 2018-2029
Figure 44. Brazil Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Sales Market Share, 2018-2029
Figure 48. Turkey Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Revenue, (US$, Mn), 2018-2029
Figure 52. Global Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) by Region, 2022 VS 2029
Figure 54. Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • アジュバント使用インフルエンザワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み
  • ヒト用狂犬病ワクチン接種のグローバル市場展望 2023年-2029年：ベロ細胞、BHK、ニワトリ胚細胞、ヒト二倍体細胞、その他
  • 不活化ポリオウイルスワクチンのグローバル市場展望 2023年-2029年：ヒト二倍体細胞、サル腎臓細胞
  • 組換えヒト凝固VIIaの世界市場2023年：プレフィルドシリンジ、バイアル
  • 組換え活性型凝固第VII因子のグローバル市場展望 2023年-2029年：バイアル、プレフィルドシリンジ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14329 )"人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）のグローバル市場展望 2023年-2029年：バイアル、充填済み" (英文：Freeze-Dried Human Rabies Vaccine (Human Diploid Cells) Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。